Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Fulgent Genetics Inc., 3 years.
Fulgent Genetics Inc.
Director
AtriCure Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AtriCure Inc. May 18, 202699.4%
-
Fulgent Genetics Inc. May 14, 202673.0%
-
AtriCure Inc. May 19, 202597.2%
-
Fulgent Genetics Inc. May 15, 202570.8%
-
Fulgent Genetics Inc. May 16, 202485.8%
-
AtriCure Inc. May 13, 202498.6%
-
AtriCure Inc. May 25, 202398.2%
-
Fulgent Genetics Inc. May 18, 202398.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2026 | AtriCure Inc. | Open-market sale | −5,313 | $54.22 | $288,071 |
| May 18, 2026 | AtriCure Inc. | Grant or award | +6,144 | — | — |
| May 14, 2026 | Fulgent Genetics Inc. | Grant or award | +11,117 | — | — |
| Aug 6, 2025 | AtriCure Inc. | Open-market sale | −2,452 | $36.82 | $90,283 |
| May 19, 2025 | AtriCure Inc. | Grant or award | +5,401 | — | — |
| May 15, 2025 | Fulgent Genetics Inc. | Grant or award | +8,982 | — | — |
| May 16, 2024 | Fulgent Genetics Inc. | Grant or award | +4,000 | — | — |
| May 13, 2024 | AtriCure Inc. | Grant or award | +7,788 | — | — |
| May 25, 2023 | AtriCure Inc. | Grant or award | +3,186 | — | — |
| Jan 3, 2023 | Fulgent Genetics Inc. | Grant or award | +4,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.